What the preprint reports
Nura Brimo of Duke University and Dilek Cokeliler Serdaroglu of Baskent University have posted a preprint that re-audits a completed electrospinning campaign for regenerative endodontics, asking what its data can and cannot decide (bioRxiv, posted October 30, 2026). The campaign, a 2020 MSc thesis at Baskent University with biological endpoints published separately in 2023, spun 25 poly(vinylpyrrolidone) (PVP) fiber formulations carrying metronidazole, ciprofloxacin, minocycline, or Ca(OH)2, the same drug set as triple antibiotic paste. The authors use simple models as instruments for constraint discovery, not prediction, and they state plainly that the source study “did not consider the kinetics of drug release,” so no release curve exists for any mat. The preprint is a workshop paper for the NeurIPS 2026 AI for Accelerated Materials Design session and is not peer reviewed.
What the models can decide
The audit’s central finding is how little the modeling adds. Logistic regression predicts fine-fiber formation at 96 percent leave-one-out accuracy, but a depth-one decision stump hits the same number, and the gain over the 80 percent majority baseline is not significant (exact McNemar p = 0.125). The 96 percent figure also rests on how mixture loading is read: when each antibiotic in the double- and triple-antibiotic series is encoded per component rather than as a summed label, accuracy falls to 84 percent (72 percent with whole formulation families held out), and under a strict sub-micron target the model reaches 70.8 percent (17 of 24), no better than majority. Diameter models interpolate within formulation families (ridge MAE 193 nm, 95 percent CI 96 to 317 nm) and fail across them (R-squared below zero). Of the 25 formulations, 20 formed fine fibers with reported means of 257 to 1873 nm; five are retained as failures, including metronidazole at 20 and 25 percent, which gave coarse microfibers of 10.2 and 7.8 micrometers.
What the carrier evidence says
Because the campaign never measured release, the authors assemble a same-drug, cross-carrier evidence table from the literature: 17 bounded metronidazole and ciprofloxacin observations from seven studies, with three further studies contributing qualitative statements only. The pattern is consistent. Water-soluble carriers release fast: all five PVP and PVA rows completed release within their observation windows, PVP within 8 hours (one report: 94 percent within 5 minutes) and thick PVA mats within about 80 hours. Water-insoluble monolithic carriers (ethyl cellulose, PVAc, PCL, PMMA, PLA) release slowly and incompletely: none of the eight rows reached 90 percent within windows of 3 hours to 80 days, and the fraction released at the last report ranged from 1.5 to 50 percent. Architecture fills the gap: blended, core-shell, and thicker-mat designs released over 3 to 28 days. Against a clinical dressing interval of one to four weeks between appointments, as the authors frame it from endodontic guidance, a PVP mat that empties in hours carries a carrier-limited release risk: the drug may be gone long before the second visit. The authors are careful to call this a risk rather than a proven ceiling, noting that one dissolution experiment on the actual mats would confirm or overturn it.
What it does not show
This is a reanalysis of a 25-row dataset, not new experiments, and it has not passed peer review. The release table is cross-carrier inference: no fiber from the campaign itself has ever sat in a dissolution bath, so the headline risk is assembled from other groups’ mats at other loadings. The morphology models describe one polymer, one solvent system, one spinner. The biological screen (worst-case minimum inhibitory concentration over four organisms, plus ordinal 72-hour MTT cytocompatibility) keeps three necessarily nondominated options: double antibiotic paste, its fiber mat, and Ca(OH)2 paste, with Ca(OH)2 fibers possibly nondominated; triple antibiotic paste is dominated by the double-antibiotic version in this dataset, and its fiber mat by the double-antibiotic mat. Those rankings are conditional on the four tested organisms and the censoring conventions the authors document, not on clinical outcomes in teeth.
Where it sits in the field
For the pulp and dentin repair program, the preprint’s practical point is about the disinfection step that precedes any regenerative outcome. Triple antibiotic paste is already known to be toxic to stem cells of the apical papilla at clinical concentrations and its minocycline component stains the crown, which is why fiber-carrier alternatives are being explored at all; this audit shows the leading water-soluble carrier candidate may fail the dressing-interval requirement on release kinetics alone, while slower carriers exist but come from different polymer families than the ones the field has optimized for spinning. It also sharpens the field assessment: the interesting constraint here is pharmaceutical (how long does the payload stay in the canal), and it was invisible to the original campaign because release was never measured. The paper’s own recommended next step, a single dissolution experiment, is unusually cheap as field bottlenecks go.
Where we differ from the coverage
There is no press coverage of this preprint to differ from. Where we would push back is on the abstract’s own headline: “logistic regression predicts fine-fiber formation at 96 percent” is the sentence a reader will remember, and the paper itself demonstrates that the sentence is nearly empty, because a one-threshold rule does as well, the margin over guessing the majority class is statistically undetectable on 25 rows, and the number moves with how a recipe label is interpreted. The preprint knows this and says so; anyone citing its 96 percent without the McNemar test and the encoding caveat is citing a constraint study as if it were a prediction breakthrough.